We are live on ! Find out more
H

HoyleCohen Portfolio holdings

AUM $1.32B
1-Year Est. Return 27.05%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$629M
AUM Growth
+$43M
Cap. Flow
-$9.68M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.07%
Holding
200
New
10
Increased
51
Reduced
94
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.07M
2
DXD icon
ProShares UltraShort Dow 30
DXD
+$536K
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$511K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$298K
5
AMT icon
American Tower
AMT
+$228K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$3.65M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.43M
3
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$639K
4
SDS icon
ProShares UltraShort S&P500
SDS
+$590K
5
AAPL icon
Apple
AAPL
+$514K

Sector Composition

Rank Sector Weight
1 Technology 20.18%
2 Financials 12.6%
3 Communication Services 9.36%
4 Healthcare 8.82%
5 Industrials 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
176
Ford
F
$57.3B
$267K 0.04%
28,732
-4,221
-13% -$37.9K
ROP icon
177
Roper Technologies
ROP
$36.3B
$266K 0.04%
750
– –
ADBE icon
178
Adobe
ADBE
$89.5B
$262K 0.04%
794
-32
-4% -$9.41K
MIDD icon
179
Middleby
MIDD
$6.05B
$255K 0.04%
2,328
– –
O icon
180
Realty Income
O
$61.2B
$248K 0.04%
3,472
-53
-2% -$3.95K
GSK icon
181
GSK
GSK
$103B
$242K 0.04%
4,121
-163
-4% -$9.07K
MS icon
182
Morgan Stanley
MS
$337B
$231K 0.04%
+4,525
New +$214K
PFF icon
183
iShares Preferred and Income Securities ETF
PFF
$13.2B
$218K 0.03%
5,795
+150
+3% +$5.6K
SPGI icon
184
S&P Global
SPGI
$126B
$218K 0.03%
+800
New +$208K
PGHY icon
185
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$221M
$217K 0.03%
9,517
+119
+1% +$2.71K
SUSA icon
186
iShares ESG Optimized MSCI USA ETF
SUSA
$3.98B
$213K 0.03%
+3,180
New +$203K
VAR
187
DELISTED
Varian Medical Systems, Inc.
VAR
$213K 0.03%
+1,500
New +$191K
WEC icon
188
WEC Energy
WEC
$37.7B
$211K 0.03%
2,292
– –
BND icon
189
Vanguard Total Bond Market
BND
$157B
$207K 0.03%
+2,473
New +$208K
TMO icon
190
Thermo Fisher Scientific
TMO
$211B
$206K 0.03%
+635
New +$193K
STOR
191
DELISTED
STORE Capital Corporation
STOR
$202K 0.03%
+5,425
New +$210K
AKTS
192
DELISTED
Akoustis Technologies Inc
AKTS
$132K 0.02%
+16,500
New +$129K
BMY.RT
193
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$109K 0.02%
+36,252
New +$94.3K
TEVA icon
194
Teva Pharmaceuticals
TEVA
$35.9B
$98K 0.02%
10,025
-5,600
-36% -$50K
HIND
195
Vyome Holdings
HIND
$14.5M
– –
0
– –
GPN icon
196
Global Payments
GPN
$22.1B
– –
-1,485
Closed -$236K
SDS icon
197
ProShares UltraShort S&P500
SDS
$406M
– –
-800
Closed -$590K
SLV icon
198
iShares Silver Trust
SLV
$28.1B
– –
-13,100
Closed -$209K
WM icon
199
Waste Management
WM
$95.9B
– –
-1,826
Closed -$210K
CELG
200
DELISTED
Celgene Corp
CELG
– –
-36,752
Closed -$3.65M
4 5 6 7
8

Similar funds

PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
GP
Girard Partners King Of Prussia, Pennsylvania $1.06B AUM 17.26% 1-Year Est. Return
AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

HoyleCohen's Q4 2019 Portfolio in Review

As of Q4 2019, HoyleCohen held 200 positions worth $629M, up 7.3% from $586M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HoyleCohen's Q4 2019 filing shows 10 new, 51 increased, 94 reduced and 5 closed positions. Its largest new stake was ProShares UltraShort Dow 30: 4,400 shares worth $496K. The largest sale was Celgene Corp, an estimated $3.65M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • HoyleCohen's largest Q4 2019 buy was ProShares UltraShort Dow 30: 4,400 shares worth $496K.
  • HoyleCohen added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.07M increase.
  • HoyleCohen's biggest Q4 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.43M.
  • HoyleCohen fully exited Celgene Corp in Q4 2019, selling an estimated $3.65M.
  • HoyleCohen's ten largest holdings make up 31% of its $629M portfolio in Q4 2019.
  • HoyleCohen opened 10 new positions and closed 5 in Q4 2019.
  • HoyleCohen's portfolio value rose 7.3% quarter-over-quarter to $629M.

Based on HoyleCohen's 13F filing for Q4 2019, filed 10 Feb 2020.